GB1105178A - Improvements in or relating to antigens suitable for the diagnosis of hepatitis - Google Patents

Improvements in or relating to antigens suitable for the diagnosis of hepatitis

Info

Publication number
GB1105178A
GB1105178A GB4882565A GB4882565A GB1105178A GB 1105178 A GB1105178 A GB 1105178A GB 4882565 A GB4882565 A GB 4882565A GB 4882565 A GB4882565 A GB 4882565A GB 1105178 A GB1105178 A GB 1105178A
Authority
GB
United Kingdom
Prior art keywords
virus
hepatitis
diagnosis
relating
inactivated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4882565A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB4882565A priority Critical patent/GB1105178A/en
Publication of GB1105178A publication Critical patent/GB1105178A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A preparation useful in the diagnosis of viral hepatitis comprises a physiologically acceptable suspension of antigenic components of active or inactivated human hepatitis virus obtained by extracting virus-containing material with diethyl ether or chloroform and subsequently evaporating the solvent. Inactivated virus used may be obtained by culturing the virus on animal kidney tissue cells and inactivating the virus, e.g. by treatment with formalin. Cutaneous or intracutaneous application of the antigen gives a positive reaction to hepatitis infection (a red papula or swelling and generalized reddening) after 12 to 48 hours.
GB4882565A 1965-11-17 1965-11-17 Improvements in or relating to antigens suitable for the diagnosis of hepatitis Expired GB1105178A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB4882565A GB1105178A (en) 1965-11-17 1965-11-17 Improvements in or relating to antigens suitable for the diagnosis of hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4882565A GB1105178A (en) 1965-11-17 1965-11-17 Improvements in or relating to antigens suitable for the diagnosis of hepatitis

Publications (1)

Publication Number Publication Date
GB1105178A true GB1105178A (en) 1968-03-06

Family

ID=10450050

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4882565A Expired GB1105178A (en) 1965-11-17 1965-11-17 Improvements in or relating to antigens suitable for the diagnosis of hepatitis

Country Status (1)

Country Link
GB (1) GB1105178A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2502154A1 (en) * 1981-03-30 1982-09-24 Trepo Christian PROCESS FOR PREPARING ANTIGENS FOR VIRAL HEPATITIS NANB, AND APPLICATION TO THE REAGENT FOR THE DIAGNOSIS AND PROGNOSIS OF INFECTIONS CAUSED BY VIRAL HEPATITIS VIRUSES
EP0058676B1 (en) * 1980-07-09 1986-10-08 Connaught Laboratories Limited Non-a, non-b hepatitis assay and vaccine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058676B1 (en) * 1980-07-09 1986-10-08 Connaught Laboratories Limited Non-a, non-b hepatitis assay and vaccine
FR2502154A1 (en) * 1981-03-30 1982-09-24 Trepo Christian PROCESS FOR PREPARING ANTIGENS FOR VIRAL HEPATITIS NANB, AND APPLICATION TO THE REAGENT FOR THE DIAGNOSIS AND PROGNOSIS OF INFECTIONS CAUSED BY VIRAL HEPATITIS VIRUSES
WO1982003330A1 (en) * 1981-03-30 1982-10-14 Christian Trepo Method for the preparation of antigens of the viral hepatitis nanb,and application to the preparation of a reaction agent allowing the diagnostic and pronostic of infections caused by the viruses of viral hepatitis

Similar Documents

Publication Publication Date Title
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
DK158743C (en) PROCEDURE FOR PREPARING A LIVING, WEAKED Hepatitis A VIRUS AND DIAGNOSTIC PREPARATION OBTAINED BY THE PROCEDURE
ES336810A1 (en) Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains
ES379641A1 (en) Ethylethyleneimine as an inactivation agent
SE7512828L (en) CALICIVIRUSVACCIN
Turner et al. Inactivated smallpox vaccine. A comparison of inactivation methods
Simpson et al. Vervet monkey disease: experimental infection of monkeys with the causative agent, and antibody studies in wild-caught monkeys
GB1105178A (en) Improvements in or relating to antigens suitable for the diagnosis of hepatitis
ES2056075T3 (en) MONOCLONAL ANTIBODIES FOR SPECIFIC ANTIGENIC REGIONS OF HUMAN IMMUNODEFICIENCY VIRUSES AND PROCEDURES FOR ITS USE.
Penhale et al. The immunodepressive effect of rinderpest virus
Atherton et al. Propagation in tissue culture of the virus of infectious laryngotracheitis of fowls.
ES355121A1 (en) Procedure for the preparation of an antigen-free vaccine. (Machine-translation by Google Translate, not legally binding)
ATE21484T1 (en) HEPATITIS A VIRUS ADAPTED TO HUMAN FIBROBLAST CELLS.
ES8107024A1 (en) Feline infectious peritonitis vaccine and process for its preparation.
CARLSTROM Relation of measles to other viruses
Hutt The immune response to infection with vaccinia virus in mice: I. Infection and the production of antibody neutralizing cell-associated and cell-free virus
FR2187909A1 (en) Stable antigens - by freeze-drying antigen bonded to red blood cells
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same
Lycke Studies of the accuracy of the guinea pig test for estimating antigenicity of poliomyelitis virus preparations
SU460749A1 (en) The method of obtaining antigenic preparations from cultures of bacteria of the intestinal group
Masiga et al. Fate of the T1 strain of Mycoplasma mycoides in cattle following vaccination
DK477180A (en) VACCINE AND PROCEDURE FOR PREPARING IT
Williams et al. Susceptibility of rodents to Japanese encephalitis virus.
JPS56115724A (en) Prophilaxis and remedy for avian infectious coryza
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus